PAPER Van der Schyf CJ, Geldenhuys WJ
SEARCH RESULTS
330907 RESULTS
PAPER Wexler EM, Rosen E, Lu D, Osborn GE, Martin E, Raybould H, Geschwind DH
Genome-wide analysis of a Wnt1-regulated transcriptional network implicates neurodegenerative pathways.
Sci Signal. 2011 Oct 4;4(193):ra65. PubMed: 21971039PAPER Jing F, Mogi M, Sakata A, Iwanami J, Tsukuda K, Ohshima K, Min LJ, Steckelings UM, Unger T, Dahlöf B, Horiuchi M
Direct stimulation of angiotensin II type 2 receptor enhances spatial memory.
J Cereb Blood Flow Metab. 2011 Oct 5; PubMed: 21971355PAPER Chapuis J, Vingtdeux V, Capiralla H, Davies P, Marambaud P
Gas1 Interferes with AβPP Trafficking by Facilitating the Accumulation of Immature AβPP in Endoplasmic Reticulum-Associated Raft Subdomains.
J Alzheimers Dis. 2012 Jan 1;28(1):127-35. PubMed: 21971401PAPER Insua D, Corredoira A, González-Martínez A, Suárez ML, Santamarina G, Sarasa M, Pesini P
Expression of p75NTR, a Marker for Basal Forebrain Cholinergic Neurons, in Young and Aged Dogs with or without Cognitive Dysfunction Syndrome.
J Alzheimers Dis. 2011 Oct 4; PubMed: 21971402PAPER Lewczuk P, Popp J, Lelental N, Kölsch H, Maier W, Kornhuber J, Jessen F
Cerebrospinal Fluid Soluble Amyloid-β Protein Precursor as a Potential Novel Biomarkers of Alzheimer's Disease.
J Alzheimers Dis. 2012 Jan 1;28(1):119-25. PubMed: 21971403PAPER Gallagher JJ, Finnegan ME, Grehan B, Dobson J, Collingwood JF, Lynch MA
Modest Amyloid Deposition is Associated with Iron Dysregulation, Microglial Activation, and Oxidative Stress.
J Alzheimers Dis. 2012 Jan 1;28(1):147-61. PubMed: 21971404PAPER Baker LD, Bayer-Carter JL, Skinner J, Montine TJ, Cholerton BA, Callaghan M, Leverenz JB, Walter BK, Tsai E, Postupna N, Lampe J, Craft S
High-Intensity Physical Activity Modulates Diet Effects on Cerebrospinal Amyloid-β Levels in Normal Aging and Mild Cognitive Impairment.
J Alzheimers Dis. 2012;28(1):137-46. PubMed: 21971406PAPER Kaneai N, Arai M, Takatsu H, Fukui K, Urano S
Vitamin e inhibits oxidative stress-induced denaturation of nerve terminal proteins involved in neurotransmission.
J Alzheimers Dis. 2012;28(1):183-9. PubMed: 21971407PAPER Sanchez MM, Moghadam S, Naik P, Martin KJ, Salehi A
Hippocampal network alterations in Alzheimer's disease and Down syndrome: from structure to therapy.
J Alzheimers Dis. 2011;26 Suppl 3:29-47. PubMed: 21971449PAPER Fennema-Notestine C, Panizzon MS, Thompson WR, Chen CH, Eyler LT, Fischl B, Franz CE, Grant MD, Jak AJ, Jernigan TL, Lyons MJ, Neale MC, Seidman LJ, Tsuang MT, Xian H, Dale AM, Kremen WS
Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age.
J Alzheimers Dis. 2011;26 Suppl 3:49-60. PubMed: 21971450PAPER Boccardi M, Ganzola R, Bocchetta M, Pievani M, Redolfi A, Bartzokis G, Camicioli R, Csernansky JG, de Leon MJ, Detoledo-Morrell L, Killiany RJ, Lehéricy S, Pantel J, Pruessner JC, Soininen H, Watson C, Duchesne S, Jack CR, Frisoni GB
Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol.
J Alzheimers Dis. 2011;26 Suppl 3:61-75. PubMed: 21971451PAPER Tosun D, Schuff N, Shaw LM, Trojanowski JQ, Weiner MW,
Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data.
J Alzheimers Dis. 2011;26 Suppl 3:77-90. PubMed: 21971452PAPER Kerchner GA
Ultra-high field 7T MRI: a new tool for studying Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:91-5. PubMed: 21971453PAPER Weih M, Degirmenci U, Kreil S, Suttner G, Schmidt D, Kornhuber J, Lewczuk P, Kuwert T
Nuclear medicine diagnostic techniques in the era of pathophysiology-based CSF biomarkers for Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:97-103. PubMed: 21971454Current Filters
No filters selected